Title of article :
Intravitreal Bevacizumab for Pseudophakic Cystoid Macular Edema; a Systematic Review
Author/Authors :
Ghasemi Falavarjani, Khalil Eye Research Center - Rassoul Akram Hospital - Tehran University of Medical Sciences , Parvaresh, Mohammad-Mehdi Eye Research Center - Rassoul Akram Hospital - Tehran University of Medical Sciences , Modarres, Mehdi Eye Research Center - Rassoul Akram Hospital - Tehran University of Medical Sciences , Hashemi, Masih Eye Research Center - Rassoul Akram Hospital - Tehran University of Medical Sciences , Samiy, Nasrollah Retina Institute of the Carolinas, North Carolina, USA
Abstract :
Cystoid macular edema (CME) is a major cause of decreased vision after complicated or
uncomplicated cataract surgery. This paper reviews the use of intravitreal bevacizumab
(IVB) injection for treatment of pseudophakic CME. In a literature search of all articles
available on Medline and Scopus databases, 11 studies including one prospective and
4 retrospective studies, 4 case reports, one letter to editor and one review article were
identified. All articles except one, reported the use of IVB for chronic CME unresponsive
to at least one conventional treatment modality. The level of evidence for all studies was
categorized as low or very low. Although intravitreal bevacizumab might be effective
for many cases of pseudophakic CME, its use should be reserved for eyes unresponsive
to conventional treatment modalities.
Keywords :
Cystoid Macular Edema , Cataract Surgery , Intravitreal Injection , Bevacizumab Anti Vascular Endothelial Growth Factor
Journal title :
Astroparticle Physics
